Heartseed
PublicHeartseed is now publicly traded
The data on this page reflects Heartseed's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series D
May 25, 2023
Total Funding Raised
$28.7M
Company Overview
Heartseed (TKS: 219A) is a biotechnology company focused on developing and commercializing iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.
Sector
Biotech
AI Layer
Non-AI
Keywords
allogeneic iPSC-derived ventricular cardiomyocyte spheroidsiPSC-derived cardiomyocyte therapycell therapy for severe heart failurecardiac remuscularization therapyregenerative medicine for heart failureallogeneic cell therapy for heart failurebiotech therapy licensing modelinduced pluripotent stem cell (iPSC) therapytherapy for reduced Left Ventricular Ejection Fraction (HFrEF)cell therapy administration deviceHLA knock-out iPSC researchautologous iPSC-derived cardiomyocyte research
Heartseed Comparables
Compare Heartseed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XellSmart | 52% | |
| Vision Care Inc. | 50% | |
| Myoridge Co., Ltd. | 45% | |
Heartseed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 25, 2023 | ||||
| Series D | May 25, 2023 |
Heartseed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series D |
| Medical Incubator Japan | Series D |
| Sumitomo Mitsui Trust Investment | Series D |
| Arcus South East Asia | Series D |
| SMBC Venture Capital | Series D |
| UTokyo Innovation Platform Co., Ltd. | Series D |
| SBI Investment Co., Ltd. | Series D |
Heartseed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersTokyo, Tokyo
Employee Range20
Year Founded2015
Last FundingMay 25, 2023